127
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study

, , &
Pages 3705-3727 | Published online: 20 Jul 2015

References

  • JellingerKASetinekUDrlicekMBöhmGSteurerALintnerFNeuropathology and general autopsy findings in AIDS during the last 15 yearsActa Neuropathol2000100221322010963370
  • BaddleyJWSalzmanDPappasPGFungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical featuresClin Transplant200216641942412437621
  • DismukesWECloudGGallisHATreatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeksN Engl J Med198731763343413299095
  • FennellyAMSlenkerAKMurphyLCMoussouttasMDeSimoneJACandida cerebral abscesses: a case report and review of the literatureMed Mycol201351777978423651179
  • OhtsukiSTerasakiTContribution of carrier-mediated transport systems to the blood–brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and developmentPharm Res20072491745175817619998
  • MansourAFoxCABurkeSAkilHWatsonSJImmunohistochemical localization of the cloned μ opioid receptor in the rat CNSJ Chem Neuroanat1995842833057669273
  • ShibataMYamadaSKumarSRClearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood–brain barrierJ Clin Invest2000106121489149911120756
  • LaronZInsulin and the brainArch Physiol Biochem2009115211211619485707
  • CôtéJSavardMBovenziVSelective tumor blood–brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH) Arg(9)]-BK in a F98 glioma rat model: an MRI studyNeuropeptides201044217718520080302
  • SaavedraJMEmerging features of brain angiotensin receptorsRegul Pept1999851314510588448
  • MoscatoEHPengXJainAParsonsTDDalmauJBalice-GordonRJAcute mechanisms underlying antibody effects in anti–N-methyl-D-aspartate receptor encephalitisAnn Neurol201476110811924916964
  • LaniusRAShawCAWageyRKriegerCCharacterization, distribution, and protein kinase C-mediated regulation of [35S] glutathione binding sites in mouse and human spinal cordJ Neurochem19946311551608207424
  • GeldenhuysWWehrungDGroshevAHiraniASutariyaVBrain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancersPharm Dev Technol201520449750624597667
  • WangXLiJXuCScopine as a novel brain-targeting moiety enhances the brain uptake of chlorambucilBioconjug Chem201425112046205425350514
  • GuptaBLevchenkoTSMongaytDATorchilinVPMonoclonal antibody 2C5-mediated binding of liposomes to brain tumor cells in vitro and in subcutaneous tumor model in vivoJ Drug Target200513633734316278153
  • UlbrichKHekmataraTHerbertEKreuterJTransferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)Eur J Pharm Biopharm200971225125618805484
  • LeeDHRötgerCAppeldoornCCGlutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitisJ Neuroimmunol20142741–29610125037177
  • ChangJJallouliYKroubiMCharacterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood–brain barrierInt J Pharm2009379228529219416749
  • GuoNMcIntoshCShawCGlutathione: new candidate neuropeptide in the central nervous systemNeuroscience19925148358421336827
  • KannanRKuhlenkampJFJeandidierETrinhHOokhtensMKaplowitzNEvidence for carrier-mediated transport of glutathione across the blood–brain barrier in the ratJ Clin Invest1990856200920131971830
  • BéduneauASaulnierPBenoitJPActive targeting of brain tumors using nanocarriersBiomaterials200728334947496717716726
  • KangYSPardridgeWMBrain delivery of biotin bound to a conjugate of neutral avidin and cationized human albuminPharm Res1994119125712647816753
  • ChengRFengFMengFDengCFeijenJZhongZGlutathi-one-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryJ Control Release2011152121221295087
  • SchaefferHEKrohnDLLiposomes in topical drug deliveryInvest Ophthalmol Vis Sci19822222202277056633
  • TorchilinVPLiposomes as targetable drug carriersCrit Rev Ther Drug Carrier Syst198421651153913530
  • ImmordinoMLDosioFCattelLStealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialInt J Nanomedicine20061329717717971
  • TurkMJWatersDJLowPSFolate-conjugated liposomes preferentially target macrophages associated with ovarian carcinomaCancer Lett2004213216517215327831
  • MaruyamaKIntracellular targeting delivery of liposomal drugs to solid tumors based on EPR effectsAdv Drug Deliv Rev201163316116920869415
  • PornpattananangkulDZhangLOlsonSBacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infectionJ Am Chem Soc2011133114132413921344925
  • PanditJGargMJainNKMiconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infectionJ Liposome Res201424216317224479833
  • HirakawaYKijimaHBehavioral analysis of glutathione receptor of HydraJ Comp Physiol198013717381
  • OjaSSJanákyRVargaVSaransaariPModulation of glutamate receptor functions by glutathioneNeurochem Int2000372–329930610812215
  • OgitaKYonedaYPossible presence of [3H] glutathione (GSH) binding sites in synaptic membranes from rat brainNeurosci Res1987464864962891093
  • OgitaKYonedaYTemperature-dependent and -independent apparent binding activities of [3H] glutathione in brain synaptic membranesBrain Res1988463137463196910
  • ReevesJPDowbenRMFormation and properties of thin-walled phospholipid vesiclesJ Cell Physiol196973149605765779
  • SzokaFJrPapahadjopoulosDComparative properties and methods of preparation of lipid vesicles (liposomes)Annu Rev Biophys Bioeng1980914675086994593
  • ElhissiAMO’NeillMARobertsSATaylorKMA calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid–liposome interactions for liposomes prepared by thin film and proliposome methodsInt J Pharm2006320112413016765001
  • GuoJPingQJiangGHuangLTongYChitosan-coated liposomes: characterization and interaction with leuprolideInt J Pharm2003260216717312842337
  • EgelhaafSUWehrliEAdrianMSchurtenbergerPDetermination of the size distribution of lecithin liposomes: a comparative study using freeze fracture, cryoelectron microscopy and dynamic light scatteringJ Microsc19961843214228
  • MatsuzakiKMuraseOSugishitaKOptical characterization of liposomes by right angle light scattering and turbidity measurementBiochim Biophys Acta20001467121922610930524
  • MatosCde CastroBGameiroPLimaJLReisSZeta-potential measurements as a tool to quantify the effect of charged drugs on the surface potential of egg phosphatidylcholine liposomesLangmuir200420236937715743080
  • AnabousiSLaueMLehrCMBakowskyUEhrhardtCAssessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopyEur J Pharm Biopharm200560229530315939240
  • KodamaTTomitaNHorieSMorphological study of acoustic liposomes using transmission electron microscopyJ Electron Microsc (Tokyo)201059318719619906662
  • HaoYZhaoFLiNYangYLiKStudies on a high encapsulation of colchicine by a niosome systemInt J Pharm20022441738012204566
  • Du PlessisJRamachandranCWeinerNMüllerDGThe influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storageInt J Pharm19961272273278
  • WatsonPMPatersonJCThomGGinmanULundquistSWebsterCIModelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood–brain barrier and blood-spinal cord barrierBMC Neurosci20131415923773766
  • AdrianJEPoelstraKScherphofGLInteraction of targeted liposomes with primary cultured hepatic stellate cells: involvement of multiple receptor systemsJ Hepatol200644356056716368158
  • MüllerKNahdeTFahrAMüllerRBrüsselbachSHighly efficient transduction of endothelial cells by targeted artificial virus-like particlesCancer Gene Ther20018210711711263526
  • De MelloTRBusfieldSDunlopSAPlantGWCulture conditions affect proliferative responsiveness of olfactory ensheathing glia to neuregulinsGlia200755773474517348025
  • Moreno-FloresMTLimFMartín-BermejoMJDíaz-NidoJAvilaJWandosellFImmortalized olfactory ensheathing glia promote axonal regeneration of rat retinal ganglion neuronsJ Neurochem200385486187112716418
  • Ramón-CuetoANieto-SampedroMGlial cells from adult rat olfactory bulb: immunocytochemical properties of pure cultures of ensheathing cellsNeuroscience19924712132201374539
  • PerilloEAllard-VannierEFalangaAQuantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cellsInt J Pharm20154881–2596625891256
  • HuthUSSchubertRPeschka-SüssRInvestigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imagingJ Control Release2006110349050416387383
  • ChenWCCompletoGCSigalDSCrockerPRSavenAPaulsonJCIn vivo targeting of B-cell lymphoma with glycan ligands of CD22Blood2010115234778478620181615
  • ZhangXLiuXGongTSunXZhangZRIn vitro and in vivo investigation of dexibuprofen derivatives for CNS deliveryActa Pharmacol Sin201233227928822301864
  • GarbuzenkoOZalipskySQazenMBarenholzYElectrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymersLangmuir20052162560256815752053
  • WebbMSSaxonDWongFMComparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristineBiochim Biophys Acta1998137222722829675310
  • KommareddySAmijiMPreparation and evaluation of thiolmodified gelatin nanoparticles for intracellular DNA delivery in response to glutathioneBioconjug Chem20051661423143216287238
  • HarrisJMMartinNEModiMPegylationClin Pharmacokinet200140753955111510630
  • XuXYuZZhuYWangBEffect of sodium oleate adsorption on the colloidal stability and zeta potential of detonation synthesized diamond particles in aqueous solutionsDiam Relat Mater2005142206212
  • RobertsMALocascio-BrownLMacCrehanWADurstRALiposome behavior in capillary electrophoresisAnal Chem199668193434344021619277
  • SriwongsitanontSUenoMPhysicochemical properties of PEG-grafted liposomesChem Pharm Bull (Tokyo)20025091238124412237543
  • LiuDHuangLRole of cholesterol in the stability of pH-sensitive, large unilamellar liposomes prepared by the detergent-dialysis methodBiochim Biophys Acta198998122542602730903
  • XiaoRZZengZWZhouGLWangJJLiFZWangAMRecent advances in PEG-PLA block copolymer nanoparticlesInt J Nanomedicine201051057106521170353
  • PanwarPPandeyBLakheraPCSinghKPPreparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomesInt J Nanomedicine2010510110820309396
  • CostantinoLBoraschiDIs there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?Drug Discov Today201217736737822094246
  • LiFWangJMaCGlutamate receptor-like channel 3. 3 is involved in mediating glutathione-triggered cytosolic calcium transients, transcriptional changes, and innate immunity responses in ArabidopsisPlant Physiol201316231497150923656893
  • TorchilinVPFluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fateAdv Drug Deliv Rev20055719510915518923
  • SchreierHBouwstraJLiposomes and niosomes as topical drug carriers: dermal and transdermal drug deliveryJ Control Release1994301115
  • AttiaIAEl-GizawySAFoudaMADoniaAMInfluence of a niosomal formulation on the oral bioavailability of acyclovir in rabbitsAAPS Pharm Sci Tech200784206212
  • New R.R.C. In: New R.R.C.Liposomes a Practical ApproachNew YorkOxford University Press1990132
  • MoriyamaESaitoTTokuokaYTakeuchiSKawashimaNEvaluation of the hardness of lipid bilayer membranes of liposomes by the ultrasound attenuation methodJ Oleo Sci2003528433437
  • LeeS-CLeeK-EKimJ-JLimS-HThe effect of cholesterol in the liposome bilayer on the stabilization of incorporated retinolJ Liposome Res2005153–415716616393907
  • FangJ-YHongC-TChiuW-TWangY-YEffect of liposomes and niosomes on skin permeation of enoxacinInt J Pharm20012191617211337166
  • UchegbuIFBouwstraJAFlorenceATLarge disk-shaped structures (discomes) in nonionic surfactant vesicle to micelle transitionsJ Phys Chem199296251054810553
  • KronbergBDahlmanACarlforsJKarlssonJArturssonPPreparation and evaluation of sterically stabilized liposomes: Colloidal stability, serum stability, macrophage uptake, and toxicityJ Pharm Sci20067986676712231327
  • KatoAArakawaMKondoTPreparation and stability of liposome-type artificial red blood cells stabilized with carboxymethylchitinJ Microencapsul1984121051126336519
  • ParkSHOhSGMunJYHanSSLoading of gold nanoparticles inside the DPPC bilayers of liposome and their effects on membrane fluiditiesColloids Surf B Biointerfaces200648211211816520025
  • Hernández-CasellesTVillalainJGómez-FernándezJCStability of liposomes on long term storageJ Pharm Pharmacol19904263974001979618
  • PatelVBMisraANEncapsulation and stability of clofazimine liposomesJ Microencapsul199916335736710340220
  • RotmanMWellingMMBunschotenAEnhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer’s diseaseJ Control Release20152031405025668771
  • RipJChenLHartmanRGlutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in ratsJ Drug Target201422546046724524555
  • BirngruberTRamlRGladdinesWEnhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,(®)/Doxil(®) – a cerebral open flow microperfusion pilot studyJ Pharm Sci20141031945194824801480
  • CarignanoMASzleiferIPrevention of protein adsorption by flexible and rigid chain moleculesColloids Surf B Biointerfaces200018316918210915942
  • SatulovskyJMACSzleiferIKinetic and thermodynamic control of protein adsorptionProc Natl Acad Sci U S A200097169037904110908651
  • de GennesPGConformations of polymers attached to an interfaceMacromolecules198013510691075
  • Bedu-AddoFKTangPXuYHuangLEffects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycolphospholipid conjugates with phospholipid: implications in liposomal drug deliveryPharm Res19961357107178860425
  • AllenTMHansenCMartinFRedemannCYau-YoungALiposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivoBiochim Biophys Acta19911066129362065067
  • BlumeGCevcGMolecular mechanism of the lipid vesicle longevity in vivoBiochim Biophys Acta1993114621571688452853
  • BazileDPrud’hommeCBassoulletMTMarlardMSpenlehauerGVeillardMStealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes systemJ Pharm Sci19958444934987629743
  • PeracchiaMTFattalEDesmaëleDStealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targetingJ Control Release199960112112810370176
  • CalvoPGouritinBChacunHLong-circulating PEGylated polycyanoacrylate nanoparticles as new drug cariers for brain deliveryPharm Res20011881157116611587488
  • BriggerIMorizetJAubertGPoly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targetingJ Pharmacol Exp Ther2002303392893612438511
  • LasicDDMartinFGabizonAHuangSKPapahadjopoulosDSterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation timesBiochim Biophys Acta1991107011871921751525
  • PatelHMSerum opsonins and liposomes: their interaction and opsonophagocytosisCrit Rev Ther Drug Carrier Syst19919139901544174
  • MoriAKlibanovALTorchilinVPHuangLInfluence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM 1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivoFEBS Lett199128422632662060647
  • TrösterSDMüllerUKreuterJModification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactantsInt J Pharm1990611–285100
  • LockmanPRKoziaraJRoderKEIn vivo and in vitro assessment of baseline blood–brain barrier parameters in the presence of novel nanoparticlesPharm Res200320570571312751624
  • LockmanPROyewumiMOKoziaraJMRoderKEMumperRJAllenDDBrain uptake of thiamine-coated nanoparticlesJ Control Release200393327128214644577
  • KoziaraJMLockmanPRAllenDDMumperRJIn situ blood–brain barrier transport of nanoparticlesPharm Res200320111772177814661921
  • KoziaraJMLockmanPRAllenDDMumperRJPaclitaxel nanoparticles for the potential treatment of brain tumorsJ Control Release200499225926915380635
  • SmeyneMSmeyneRJGlutathione metabolism and Parkinson’s diseaseFree Radic Biol Med2013621132523665395
  • BellarosaCBortolussiGTiribelliCThe role of ABC transporters in protecting cells from bilirubin toxicityCurr Pharm Des200915252884289219754365
  • GeldenhuysWMbimbaTBuiTHarrisonKSutariyaVBrain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancersJ Drug Target201119983784521692650
  • KreuterJNanoparticulate systems for brain delivery of drugsAdv Drug Deliv Rev2001471658111251246
  • KreuterJTransport of drugs across the blood–brain barrier by nanoparticlesCent Nerv Syst Agents Med Chem200223241249
  • KreuterJShamenkovDPetrovVApolipoprotein-mediated transport of nanoparticle-bound drugs across the blood–brain barrierJ Drug Target200210431732512164380